Skip to main content
PLOS One logoLink to PLOS One
. 2024 Mar 18;19(3):e0299745. doi: 10.1371/journal.pone.0299745

Assessing knowledge about hypertension and identifying predictors of inadequate knowledge in Saudi Arabia: A cross-sectional study

Ajiad Alhazmi 1,*,#, Hassan N Moafa 1,2,#, Mohammed Kotb 1,¤a, Louay Sayegh 1, Hassan Baydhi 1, Abdullaziz Hazzazi 1, Hassan Moafa 3,¤b, Abdulelah Hakami 4
Editor: Isaac Amankwaa5
PMCID: PMC10947669  PMID: 38498440

Abstract

Background

Globally, hypertension is among the leading causes of premature mortality. It is a noncommunicable disease characterized by a persistent state of raised blood pressure that increases the risk of cardiovascular diseases and medical conditions affecting the brain and kidneys. There is a paucity of thorough hypertension knowledge assessment among hypertensive patients in the Jazan region of Saudi Arabia. Thus, this study aimed to assess overall and specific knowledge about hypertension and to identify predictors of inadequate knowledge.

Methods

A cross-sectional study was conducted in the Jazan region of Saudi Arabia between February and April 2023. Data were collected using an online, self-administered questionnaire divided into two sections. In the first section, the characteristics of the participants were collected. In the second section, the Hypertension Knowledge-Level Scale was used to measure overall and specific knowledge areas (subdimensions). The overall and subdimensional means were tested using Mann–Whitney U and Kruskal–Wallis H tests. Furthermore, the binary logistic regression was conducted to determine inadequate knowledge predictors.

Results

In all 253 hypertensive patients were eligible for participation; almost 70% of whom were male. The mean age of the participants was 45 years (±14.7), and their mean overall knowledge score was 17.60 (±5.09), which was equivalent to 67.7% of the maximum score. In addition, 40.7% of participants had an adequate level of hypertension knowledge. The complications subdimension level of knowledge was borderline optimal. At the same time, an adequate knowledge level was detected only in the lifestyle subdimension.

Conclusion

Most patients showed inadequate levels of knowledge related to hypertension management. Diet, medical treatment, disease definition, drug compliance, and complications were subsequently the least knowledgeable subdimensions among the study population. Therefore, these subdimensions should be prioritized when planning hypertension educational interventions and during follow-up sessions, especially for patients of younger age groups and those with lower educational levels.

Introduction

One of the major causes of global premature mortality is hypertension (high blood pressure). It is defined either through specific measurements of blood pressure or through the reported use of antihypertensive medications. It is a noncommunicable disease characterized by persistently elevated blood pressure. High blood pressure is a serious medical condition that increases the risk of cardiovascular diseases and affects the brain and kidneys [1].

In a 2019 study, the global, age-standardized prevalence of hypertension was found to be 34% for men and 32% for women aged 30–78 years. These findings were similar to the levels found in 1990, when the prevalence was 32% for both men and women. While developed countries have experienced a decline in the prevalence rate of hypertension, it has increased in developing countries, where nearly two-thirds of hypertensive patients live [2]. Given that hypertension typically presents with no symptoms, an estimated 46% of patients are unaware of their condition. However, symptoms such as headache, blurred vision, and chest pain can appear in instances of extremely high blood pressure levels [1]. According to a study regarding the burden of cardiovascular disease risk factors, the prevalence rate of hypertension in Saudi Arabia in 2017 for people above 18 years was 31.4% for Saudis and 47.5% for expatriates who reside in Saudi Arabia [3]. During the same year, the Saudi Ministry of Health documented that the prevalence rate of hypertension reached 3.2% among people aged 15 to 24 years, 51.2% among those aged 55 to 64 years, and up to 70% among people aged 65 years or above. Moreover, the overall prehypertensive prevalence rate was 40.4% [4]. In particular, the prevalence rate of hypertension in the Jazan region reached 8.9% [5]. More importantly, the prevalence rate of hypertension among Saudis is predicted to increase along with the global trend [6]. As a result, the incidence of complications resulting from uncontrolled hypertension will subsequently increase.

Many risk factors can increase the risk of developing hypertension. All these factors can be attributed to two types. The first type is modifiable factors, including an unhealthy diet, physical inactivity, smoking, alcoholism, obesity, and comorbidities such as diabetes mellitus and kidney disease. The second type is uncontrollable nonmodifiable risk factors, such as family history and age [1]. Adequate knowledge of these factors and nonpharmacological approaches can positively influence hypertension management, as numerous studies have shown a positive relationship between knowledge and management of the disease [712]. Given that knowledge of hypertension management plays a significant role in prevention and control, research investigating this knowledge in hypertensive patients is vital for public health.

Several studies have assessed hypertension knowledge among hypertensive patients using the Hypertension Knowledge Level Scale (HK-LS). For example, a Palestinian study revealed that the overall mean knowledge level was equivalent to 82.8% of the maximum score [13]. A Saudi study found that the overall knowledge level was equivalent to 70.2% of the maximum scores, and the mean knowledge level differed significantly according to sex, age, educational level, and employment status [14]. A recent study conducted in various regions of Saudi Arabia showed that the overall mean knowledge level was equivalent to 68.5% of the maximum score, and the least knowledgeable subdimensions were related to drug compliance followed by diet. In contrast, the complications and lifestyle subdimensions were optimal [15]. These previous studies investigating hypertensive patients’ knowledge levels in other Saudi regions cannot be generalized to other Saudi regions, such as the Jazan region, where a higher proportion of people suffer from hypertension and its complications and where the health system is overwhelmed by emergencies and cases of communicable and genetic diseases. In addition, this region has a fairly different health system compared with other Saudi regions, particularly in terms of structural indicators [1618].

As a result of the limited data, there is a need to understand the knowledge in general and specific areas concerning hypertension in this particular region of Saudi Arabia. Therefore, this study aimed to assess the levels of overall and specific knowledge of hypertension and to identify the predictors of inadequate levels of knowledge in hypertensive patients in the Jazan region of Saudi Arabia. The results of this study could be used as baseline data for prospective studies and actions to improve hypertension management in the region.

Materials and methods

Study design and settings

A cross-sectional study was conducted using an online, self-administered questionnaire disseminated to hypertensive patients in the Jazan region from 5 February to 20 April 2023. The region is located in southwestern Saudi Arabia and comprises 13 provinces distributed in a geographical area of 13,400 km2, the region’s total area. The regional population is 1.6 million, and most live in rural areas [19]. Areas of less than 5,000 inhabitants can be defined as rural areas, while geographical areas with more than 5,000 inhabitants can be defined as urban [20, 21]. In Saudi Arabia, health care services are free of charge for all Saudi citizens, while for non-Saudis, the services are provided via health insurance companies. Health education services are available at all primary health care centers and are provided only by the family physicians working there. Most of the health care services in the Jazan region are operated mainly by the Ministry of Health, in addition to a limited number of private hospitals and medical complexes. The Jazan region has 177 primary health care centers and 284 family physicians [16, 22]. There was a ratio of 1.8 family physicians per 10,000 population in 2021 in the Jazan region. Patients with essential hypertension are screened and treated at primary health care centers, while those with secondary hypertension due to other medical conditions or who have hypertension complications are referred to secondary health care services represented by public hospitals.

Study participants and eligibility criteria

The sample size was determined using a previously suggested formula (n = z2pq/d2) [23]. It was calculated with a (95%) confidence interval and a (6%) margin of error. Due to a lack of previous studies in the Jazan region, we used the proportion of those with inadequate hypertension knowledge based on the same criteria of knowledge level classification from other regions of Saudi Arabia, which was 61.3% [2427]. A total of 253 subjects were subsequently needed.

The eligibility criteria were clarified on the first page of the online version of the survey along with the study objectives, estimated time for completing the questionnaire and notification of voluntary participation in addition to the right to withdraw from the study at any time. The criteria for participation included the following: Saudi citizenship; residence in the Jazan region; use of antihypertensive medications within the last three months; at least 18 years of age; and willingness to participate in the study, indicated by the provision of informed consent. Individuals who did not meet at least one criterion were automatically excluded. The online version of the survey was disseminated through WhatsApp groups, a popular social media platform in Saudi Arabia, with a request to forward the survey to other groups. Data were collected anonymously. This study complies with Strengthening the Reporting of Observational Studies in Epidemiology guidelines, as shown in S1 Table [28].

Data collection instrument

Study data were collected using an online, self-administered, closed-ended questionnaire developed via Google Forms. The questionnaire was divided into two sections. In the first section, data related to the characteristics of the participants, including sex, age, educational level, residency area, history of hypertension complications and time since diagnosis, were collected. Educational level was categorized according to the Saudi educational system, comprising essential and higher education. Essential education includes primary, intermediate and secondary schools. Higher education includes graduate and postgraduate studies. Participants without education at any of these levels but who could read and write were referred to as having no formal education. Participants were requested to report whether they had a history of hypertension complications and were then categorized as having either a negative or positive history. In addition, those who reported any form of complication were referred to as having a positive history of complications and were further divided according to the type of complication. Those with two or more complications were recorded as having multiple complications. The second section used the 26 items of the HK-LS instrument, which was developed by Erkoc et al. in English to assess Turkish adults’ knowledge about hypertension and its management using 22 items that are distributed across six specific areas called subdimensions, namely: disease definition, medical treatment, drug compliance, lifestyle, diet, and complications [29]. Due to the validity and reliability of the instrument in Saudi Arabia, [15] the items were translated into Arabic. However, certain modifications were applied to the scale after consultation with experts, including an addition of one item to the disease definition subdimension, and it was added to assess participants’ knowledge regarding the increased isolated systolic pressure as a form of hypertension. Also, three items were added to the lifestyle subdimension to evaluate patients’ understanding of the role of salt intake, obesity/overweight, and physical activity as essential factors for managing hypertension. The 26 items of the scale were distributed over the six subdimensions as the following: disease definition (three items); medical treatment (four items); drug compliance (three items); lifestyle (eight items); diet (two items); and complications (five items). Each item involved a complete sentence, and the participant was requested to specify whether the given statement was ‘true’, ‘false’ or ‘do not know’. Each correct answer was worth one point. Incorrect or ‘do not know’ answers received zero points. Study participants were classified as having an adequate or inadequate level of knowledge based on the number of correct responses. An adequate level of knowledge required at least 75% of the responses to be correct (20 or more out of 26 questions). If the number of correct responses was less than 75% (fewer than 20 out of 26), the participant was classified as having inadequate knowledge.

Pilot study

A pilot study was performed to assess the modified subdimensions. This phase of the study consisted of 13 participants who did not participate later in the study. The modified subdimensions were the disease definition and lifestyle subdimensions. The internal consistency of these modified subdimensions was assessed using Cronbach’s alpha, and the results indicated the reliability of these subdimensions S2 Table.

Ethical considerations

The Committee of Scientific Research at Jazan University issued ethical approval for this study on February 5, 2023 (reference number: REC-44/07/548). Written informed consent was provided by all subjects. The study was carried out in accordance with the Declaration of Helsinki, 2013. Once data were collected, they were kept secured, and only the investigators of the study had the right to access them.

Statistical analysis

Frequency and percentage distributions were calculated for categorical variables. Means and standard deviations were measured for the overall and subdimensional results of the HK-LS. Data were not normally distributed S3 Table. Therefore, nonparametric tests such as the Mann–Whitney U test and Kruskal–Wallis H test were applied to explore significant knowledge differences according to the characteristics of the participants at the overall and subdimensional levels of the HK-LS. The mean ranks are presented in S4 Table. The predictors of inadequate knowledge were identified through binary logistic regression. Cohorts with the highest means at the overall level were chosen as referent categories. For all tests, P < 0.05 was considered significant. Statistical analysis was performed using SPSS version 23 (IBM Corp., Armonk, NY, USA).

Results

Characteristics of hypertensive participants

Among a total of 634 respondents, only 253 were eligible. The rest were ineligible, and the response rate was 39.9%. Table 1 shows the characteristics of eligible participants. The total number of participants was 253; most were male (60.9%). The mean age was 46.7 (±14.7) years and ranged from 22 to 90 years. Of the total, 52.6% were from rural areas, and 41.5% had achieved higher education. We found that 32.0% of participants had hypertension for less than two years. In addition, the predominant two types of complications were mainly related to the eyes (21.7%), followed by heart-related complications (12.3%). Only 40.7% of participants were found to have an adequate level of knowledge about hypertension.

Table 1. Characteristics of the studied hypertensive participants.

Variables n/mean %/SD
Sex
 Male 154 60.9%
 Female 99 39.1%
Age
 Mean age (±SD) in years 45 (±5.1)
Age group
 <35 years 57 22.5%
 35–44 years 72 28.5%
 45–54 years 42 16.6%
 55–64 years 51 20.1%
 ≥65 years 31 12.3%
Educational level
 No formal education 50 19.7%
 Primary 17 6.7%
 Intermediate 46 18.1%
 Secondary 32 12.6%
 Higher education 108 42.5%
Residency area
 Urban 120 47.4%
 Rural 133 52.6%
History of complications
 Negative 122 48.2%
 Heart complications 31 12.3%
 Eye complications 55 21.7%
 Kidney complications 17 6.7%
 Multiple complications 28 11.1%
Duration since diagnosis
 Since less than 2 years 81 32.0%
 Since 2–5 years 63 24.9%
 Since 6–10 years 64 25.3%
 Since more than 10 years 45 17.8%
Level of knowledge
 Adequate 103 40.7%
 Inadequate 150 59.3%

SD: Standard deviation.

Overall HK-LS scores

Table 2 shows the overall mean HK-LS scores according to the characteristics of hypertensive participants. The overall mean HK-LS score was 17.60, which was equivalent to 67.7% of the maximum score. We found that the mean HK-LS score significantly increased as age and educational level increased (P = 0.022 and P < 0.001, respectively). We found a significant difference in the mean HK-LS score between participants with a positive and negative history of complications, with a mean score of 18.34 and 16.81 in those who did and did not develop hypertension complications, respectively (P = 0.017). We found a nonsignificant difference in the mean HK-LS score between female participants (18.26) and male participants (17.18) (P = 0.100).

Table 2. Overall mean HK-LS scores according to characteristics of hypertensive participants.

Variables Overall HK-LS score (Mean±SD) P value
Min–Max 0–26
All participants (N = 253) 17.60±5.09 -
Sex
 Male 17.18±5.53 0.234a
 Female 18.26±4.29
Age group
 <35 years 16.05±5.19 0.022b
 35–44 years 17.40±4.71
 45–54 years 17.95±5.36
 55–64 years 18.35±5.47
 ≥65 years 19.23±3.71
Educational level
 No formal education 14.52±6.19 <0.001b
 Primary 16.47±5.29
 Intermediate 17.52±4.45
 Secondary 17.75±5.52
 Higher education 19.20±4.24
Residency area
 Urban 17.46±5.25 0.705a
 Rural 17.74±4.97
History of complications
 Negative 16.81±5.54 0.029a
 Positive 18.34±4.55
Duration since diagnosis
 Since less than 2 years 17.09±5.03 0.535b
 Since 2–5 years 17.59±5.48
 Since 6–10 years 17.78±5.26
 Since more than 10 years 18.31±4.46

SD: Standard deviation, Min: Minimum score, Max: Maximum score.

aMann–Whitney U test,

bKruskal–Wallis H test.

HK-LS subdimension scores

Table 3 shows the mean scores for all HK-LS subdimensions according to the characteristics of the participants. The overall mean scores across the different subdimensions were 1.74 for disease definition, 2.23 for medical treatment, 2.53 for drug compliance, 6.45 for lifestyle, 1.09 for diet, and 3.57 for complications. The lifestyle subdimension had the highest mean score, while the diet subdimension had the lowest. Notably, the means for certain HK-LS subdimensions varied according to different participant variables. However, neither lifestyle nor diet subdimensions revealed a significant relationship with participant variables.

Table 3. Subdimensions of the HK-LS according to the characteristics of hypertensive participants.

Variables HK-LS Subdimensions (Mean±SD)
Disease Definition Medical Treatment Drug Compliance Lifestyle Diet Complications
Min–Max Min–Max Min–Max Min–Max Min–Max Min–Max
0–3 0–4 0–4 0–8 0–2 0–5
Sex
 Male 1.71±1.31 2.05±1.23 2.55±1.34 6.27±2.00 1.11±0.81 3.49±1.74
 Female 1.77±1.22 2.51±1.04 2.52±1.16 6.73±1.55 1.05±0.80 3.70±1.58
P valuea 0.778 0.004 0.435 0.075 0.556 0.403
Age group
 <35 years 1.60±1.29 1.89±1.22 2.18±1.42 6.00±2.00 0.89±0.72 3.49±1.68
 35–44 years 1.75±1.24 2.13±1.14 2.44±1.31 6.44±1.78 1.06±0.79 3.58±1.77
 45–54 years 1.57±1.35 2.31±1.30 2.62±1.19 6.52±1.92 1.29±0.81 3.64±1.65
 55–64 years 1.98±1.23 2.37±1.15 2.88±1.11 6.61±1.94 1.10±0.86 3.41±1.82
 ≥65 years 1.77±1.33 2.74±0.93 2.71±1.16 6.90±1.22 1.23±0.85 3.87±1.23
P valueb 0.550 0.012 0.084 0.185 0.119 0.954
Educational level
 No formal education 1.30±1.33 1.78±1.15 1.92±1.32 5.72±2.56 0.86±0.78 2.94±1.91
 Primary 1.18±1.19 1.65±1.27 2.47±1.18 6.12±2.12 1.24±0.83 3.82±1.38
 Intermediate 1.59±1.31 2.39±0.95 2.43±1.41 6.50±1.55 1.09±0.76 3.52±1.66
 Secondary 1.69±1.26 2.34±1.26 2.59±1.13 6.50±1.74 0.97±0.82 3.66±1.72
 Higher education 2.10±1.17 2.43±1.19 2.85±1.15 6.80±1.43 1.20±0.81 3.82±1.55
P valueb <0.001 0.005 <0.001 0.158 0.103 0.070
Residency area
 Urban 1.69±1.31 2.13±1.29 2.42±1.36 6.47±1.81 1.07±0.80 3.68±1.65
 Rural 1.77±1.25 2.32±1.08 2.64±1.19 6.43±1.88 1.11±0.81 3.47±1.70
P valuea 0.609 0.304 0.326 0.955 0.690 0.288
History of complications
 Negative 1.66±1.32 2.08±1.16 2.48±1.26 6.30±1.90 1.07±0.85 3.23±1.86
 Positive 1.81±1.24 2.37±1.19 2.59±1.29 6.59±1.78 1.10±0.76 3.89±1.43
P valuea 0.359 0.045 0.316 0.117 0.864 0.005
Duration since diagnosis
 Since less than 2 years 1.64±1.26 2.06±1.18 2.31±1.38 6.27±1.72 1.10±0.75 3.70±1.68
 Since 2–5 years 1.89±1.27 2.10±1.15 2.71±1.14 6.48±1.92 1.05±0.85 3.37±1.81
 Since 6–10 years 1.75±1.25 2.36±1.24 2.64±1.21 6.61±1.89 1.13±0.81 3.30±1.69
 Since more than 10 years 1.67±1.38 2.53±1.12 2.53±1.31 6.49±1.90 1.07±0.84 4.02±1.37
P valueb 0.710 0.062 0.359 0.226 0.961 0.074
Total 1.74±1.27 2.23±1.18 2.53±1.27 6.45±1.84 1.09±0.80 3.57±1.67

SD: Standard deviation, Min: Minimum score, Max: Maximum score.

aMann–Whitney U test,

bKruskal–Wallis H test.

Predictors associated with inadequate knowledge

The predictors of inadequate knowledge are listed in Table 4. The significant predictors of inadequate knowledge were younger age groups and lower educational levels in the crude and adjusted models. In addition, those who had been diagnosed with hypertension for less than two years were more likely to have an inadequate level of knowledge (COR: 2.418; 95% CI: 1.143–5.111; (P = 0.021)).

Table 4. Independent predictors of inadequate knowledge.

Predictors Crude results Adjusted results
B OR OR (95% CI) P value B OR OR (95% CI) P value
Sex
 Male 0.116 1.123 0.673–1.876 0.657 0.226 1.253 0.682–2.301 0.467
 Female Referent Referent
Age group
 <35 years 1.266 3.548 1.417–8.885 0.007 2.505 12.246 3.359–44.639 <0.001
 35–44 years 1.082 2.950 1.238–7.031 0.015 2.497 12.141 3.579–41.178 <0.001
 45–54 years 0.421 1.523 0.598–3.882 0.378 1.474 4.368 1.332–14.323 0.015
 55–64 years 0.286 1.331 0.541–3.275 0.533 0.811 2.251 0.814–6.226 0.118
 ≥65 years Referent Referent
Educational level
 No formal education 1.120 3.065 1.468–6.399 0.003 1.347 3.847 1.723–8.589 0.001
 Primary 1.253 3.500 1.073–11.419 0.038 2.066 7.893 2.078–29.984 0.002
 Intermediate 0.608 1.837 0.905–3.728 0.092 2.191 8.942 2.996–26.691 <0.001
 Secondary 0.454 1.574 0.707–3.503 0.266 1.674 5.332 1.896–14.995 0.002
 Higher education Referent Referent
Residency area
 Urban 0.056 1.058 0.640–1.748 0.827 0.052 1.053 0.593–1.868 0.860
 Rural Referent Referent
History of complications
 Negative 0.307 1.360 0.821–2.251 0.232 0.534 1.705 0.961–3.026 0.068
 Positive Referent Referent
Duration since diagnosis
 Since less than 2 years 0.883 2.418 1.143–5.111 0.021 0.229 1.257 0.494–3.197 0.631
 Since 2–5 years 0.486 1.626 0.752–3.516 0.216 0.220 1.246 0.519–2.991 0.622
 Since 6–10 years 0.449 1.566 0.727–3.374 0.252 0.376 1.457 0.619–3.430 0.389
 Since more than 10 years Referent Referent

Regression coefficient, OR: Odds ratio, CI: Confidence interval.

Discussion

Our study showed remarkable differences in the HK-LS score in a special Saudi region that has the highest population density in comparison with the rest of the regions in Saudi Arabia. Interestingly, to the best of our knowledge, our study is the only Saudi study to assess the overall and subdimensional knowledge of hypertension and identify predictors of inadequate knowledge in the Jazan region.

We found that the overall mean score of the knowledge levels of the participants was 17.60 (±5.09), which represents 67.7% of the maximum score. The majority of participants (59.3%); (95% CI: 53.0%-66.0%) were classified as having inadequate knowledge about the disease and its management. These findings at the overall level are relatively similar to those of a previous Saudi study conducted by Abualnaja OS et al. in Makkah and another recent study conducted by Alshammari SA et al. to assess the validity and reliability of the HK-LS, where they reported an overall knowledge score of 70.2% and 68.5%, respectively [14, 15]. On the other hand, many other studies conducted in the kingdom have utilized different instruments to assess knowledge. For instance, an overall mean knowledge score of 77.1% was found in the Riyadh region [30]. In the Makkah and Jeddah regions, the proportion of hypertensive patients with an adequate level of knowledge was 73.0% and 72.6%, respectively [24, 31]. In comparison, the lower mean knowledge score and number of people with an adequate level of knowledge observed in our study could be attributed to differences in the scoring systems used for assessing knowledge level, particularly the differences in assessment items.

At the subdimensional level, participants displayed adequate knowledge only in the lifestyle subdimension, as the mean was approximately 80.0% of the maximum score. The mean knowledge scores in other subdimensions were equivalent to 54.5% for diet, 58.0% for both disease definition and medical treatment, 63.3% for drug compliance, and 71.4% for complications. These results are still inadequate, especially considering that the subjects are hypertensive patients. Compared with our study, the study by Abualnaja OS et al. documented similar findings for the disease definition and drug compliance subdimensions [14]. However, deviations were observed in the subdimensions of medical treatment, lifestyle, diet and complications. In comparing these four subdimensions, participants in our study were characterized by higher knowledge only in the lifestyle subdimension. These deviations might be attributed to the urbanity of the Makkah population, in contrast to the Jazan region, where a higher proportion of people live in rural areas [19]. In addition, an African systematic review revealed a rural setting is a factor that influences the knowledge of cardiovascular diseases [32]. Furthermore, other Saudi studies identified the lowest knowledge level in the diet section [24, 26, 33].

A Ghanian study identified educational level and marital status as significant predictors of knowledge; [34] however, in our study, the significant predictors were a younger age group and lower educational level. Differences in study inclusion criteria might be responsible for this divergence in results since the study sample only included people who live in rural communities. While a diagnosis of hypertension within the previous two years was found to be a significant predictor in the current study, this was only in the crude model, and when adjusted, it appeared insignificant.

Uncontrolled hypertension can lead to serious complications such as ischemic heart attack and cerebral stroke, which require facilities that are fully equipped with advanced tools in addition to the availability of highly skilled providers to intervene early and curb the possible sequelae that may arise. For coronary vascular disease requiring cardiac catheterization, there is only one health care facility, called Mohammad bin Nasser Hospital, which is overwhelmed by 9,168 cases already registered [17]. While stroke cases require advanced facilities to provide fibrinolytic medical intervention and rehabilitation facilities, the region lacks this type of facility, and therefore, those stroke patients also add an extra overwhelming burden to the health care system in terms of regional hospital beds and extra cost. Moreover, the region’s health care system is burdened by cases of communicable and genetic diseases [16, 18]. All these factors might encourage policy-makers to draw attention to providing community-based health education that supports primary health care centers in educating patients. Knowledge about hypertension is a significant, independent contributor to successfully controlling the condition [712]. Unfortunately, social media platforms have been identified by many studies as being a significant source of misinformation that threatens public health by spreading incorrect health information and rumors about noncommunicable diseases, treatments, drugs, and lifestyles [3538]. While there have been few studies on hypertension-related social media content, one study assessed hypertension content on YouTube and found that one-third contained misleading information [39]. Hence, to maximize community-level knowledge, health care providers should be patients’ primary sources of knowledge.

Knowledge about hypertension and adherence to hypertension guidelines among physicians at primary health care centers in the Jazan region was recently investigated by Shnaimer JA et al. They assessed knowledge and adherence by adopting an assessment component from the Saudi Hypertension Management Guidelines. Strikingly, Shnaimer JA et al. revealed inadequate knowledge about hypertension among physicians, with an overall mean knowledge of 7.9 out of 16, equivalent to 49.4% of the maximum score. The mean score for adherence to hypertension guidelines was 7.11 out of 11, representing 64.6% of the maximum score. They also highlighted that the higher number of patients seen daily played a significant role in physicians’ knowledge scores and guideline adherence [6]. The provision of health education exclusively through family physicians, the ratio of whom to the Jazan regional population was 1.8 per 10,000 population in 2021, creates an effort burden for those physicians in general practices to offer proper interventional health education and promotion. Increasing the number of family physicians per 10,000 population could add extra costs, although it might improve patients’ knowledge levels about different preventable diseases. Another solution is to involve health educators who require a shorter training period and lower costs than family physicians in educating patients about several preventable risk factors that affect the progress of hypertension and other diseases. Health education interventions have been shown to significantly affect hypertension control [40, 41] and could improve knowledge about hypertension in patients. This is especially needed in the Jazan region, where there is inadequate knowledge and adherence by primary health care physicians and a low family physician per population ratio.

This study has several limitations. First, it used a cross-sectional design, which provided insights regarding the community only at the time of the study. Second, the sampling technique and the online questionnaire preclude the presentation of the whole area and the generalizability of the results. Third, our data did not involve those patients suffering from severe complications, such as cerebral stoke, due to the difficulty of communication with them. Subsequently, future studies are required to determine their knowledge level. Nevertheless, our study used the HK-LS, and this work can be considered by other researchers as adding value to the evidence for understanding the status quo and conducting future research.

Conclusion

Most patients showed inadequate levels of knowledge related to hypertension management. The inadequate level of knowledge was remarkable with young hypertensive patients and those with a lower level of education. In addition, the level of knowledge related to the subdimensions of diet, medical treatment, disease definition, drug compliance, and complications was inadequate. Therefore, to improve patients’ knowledge and enhance public health practices in Jazan, involving public health educators in primary health care services could improve patients’ knowledge about hypertension and its complications and reduce the burden on family physician burdens in the Jazan region, as indicated in the literature. Further studies are required to determine the knowledge level of hypertensive patients with severe complications such as cerebral stroke.

Supporting information

S1 File. Data.

Data of eligible participants.

(XLSX)

pone.0299745.s001.xlsx (52.8KB, xlsx)
S1 Table. STROBE checklist.

STROBE Statement—checklist of items that should be included in reports of observational studies.

(DOCX)

pone.0299745.s002.docx (24.5KB, docx)
S2 Table. Modification details.

Modifications applied to the HK-LS.

(DOCX)

pone.0299745.s003.docx (14.8KB, docx)
S3 Table. Tests of normality.

Tests of normality of dependent variables.

(DOCX)

pone.0299745.s004.docx (13.4KB, docx)
S4 Table. Mean ranks.

Mean ranks of nonparametric tests.

(DOCX)

pone.0299745.s005.docx (20.7KB, docx)

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organization. Hypertension. [Updated on 25 August 2021; accessed on 2 March 2023]. https://www.who.int/news-room/fact-sheets/detail/hypertension.
  • 2.Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021;398: 957–980. doi: 10.1016/S0140-6736(21)01330-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ahmed AM, Hersi A, Mashhoud W, Arafah MR, Abreu PC, Al Rowaily MA, et al. Cardiovascular risk factors burden in Saudi Arabia: the Africa Middle East cardiovascular epidemiological (ACE) study. J Saudi Heart Assoc 2017;29: 235–243. doi: 10.1016/j.jsha.2017.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Saudi Ministry of Health. World Hypertension Day. [Updated on 15 May 2017; accessed on 2 March 2023]. https://www.moh.gov.sa/en/HealthAwareness/healthDay/2017/Pages/HealthDay-2017-05-17.aspx.
  • 5.Alenazi AM, Alqahtani BA. National and regional prevalence rates of hypertension in Saudi Arabia: A descriptive analysis using the national survey data. Front Public Health 2023;11:1092905. doi: 10.3389/fpubh.2023.1092905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Shnaimer JA, Gosadi IM. Primary health care physicians’ knowledge and adherence regarding hypertension management guidelines in southwest of Saudi Arabia. Medicine (Baltimore) 2020;99:e19873. doi: 10.1097/MD.0000000000019873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Jankowska-Polańska B, Uchmanowicz I, Dudek K, Mazur G. Relationship between patients’ knowledge and medication adherence among patients with hypertension. Patient Prefer Adherence 2016;10: 2437–2447. doi: 10.2147/PPA.S117269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Malik A, Yoshida Y, Erkin T, Salim D, Hamajima N. Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. Nagoya J Med Sci 2014;76: 255–263. [PMC free article] [PubMed] [Google Scholar]
  • 9.Barreto MD, Reiners AA, Marcon SS. Knowledge about hypertension and factors associated with the non-adherence to drug therapy. Rev Lat Am Enfermagem 2014;22: 491–498. doi: 10.1590/0104-1169.3447.2442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gaili AA, Metwali ZM, Abdalla N, Al-Ebraheem SQ, Al–Akshar S. The Relationship Between Knowledge and Drug Adherence in Hypertensive Patients: A Cross Sectional Study in UAE. Am J Adv Drug Deliv 2016;4; 1–11. [Google Scholar]
  • 11.Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens 2020;26: 1–9. doi: 10.1186/s40885-020-00151-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Aldukhayel A, Saleh S, AlKhattaf AA, Aldawsari A. Impact of patients’ knowledge of hypertension on adherence to antihypertensive drugs in Qassim region, Saudi Arabia. Medical Science 2022;26:ms490e2547. doi: 10.54905/disssi/v26i129/ms490e2547 [DOI] [Google Scholar]
  • 13.Al Zabadi H, Tuffaha A, Abdallah S, Hussein A, Khdour M. Evaluation of hypertension knowledge among hypertensive and non-hypertensive adults: a crosssectional study from Palestine. Palestinian Medical and Pharmaceutical Journal (PMPJ) 2018;3: 67–77. doi: 10.59049/2790-0231.1055 [DOI] [Google Scholar]
  • 14.Abualnaja OS, Alharbi AA. Level of Knowledge about Hypertension and its Associated Factor among Hypertensive Patients Attending Al-Eskan Primary Health Care Center in Makkah Al-Mokarramah City, 2019 Cross-sectional study. American Journal of Sciences and Engineering Research 2022;5: 10–25. [Google Scholar]
  • 15.Alshammari SA, Alshathri AH, Aldharman SS, Alshathri AH, Abukhlaled JK, Alabdullah DW, et al. Construct Validity and Reliability of the Arabic Version of Hypertension Knowledge-Level Scale Among Saudi Population. Cureus 2022;14:e33182. doi: 10.7759/cureus.33182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Saudi Ministry of Health. Statistical Yearbook 2021. Riyadh: Ministry of Health; 2022. https://www.moh.gov.sa/en/Ministry/Statistics/book/Documents/Statistical-Yearbook-2021.pdf.
  • 17.Saudi Press Agency. Thousands treated for heart ailments in Saudi Arabia’s Jazan. Arab News. 2022 August 21. [Accessed 2023 March 3]. https://arab.news/ndzmj.
  • 18.Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med 2011;31: 289–293. doi: 10.4103/0256-4947.81540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Saudi General Authority for Statistics. Population & Demography. [Updated on 1 April 2019; accessed on 3 March 2023]. https://www.stats.gov.sa/en/1007-0.
  • 20.Moafa HN, van Kuijk SMJ, Moukhyer ME, Alqahtani DM, Haak HR. Non-Conveyance Due to Patient-Initiated Refusal in Emergency Medical Services: A Retrospective Population-Based Registry Analysis Study in Riyadh Province, Saudi Arabia. Int J Environ Res Public Health 2021;18:9252. doi: 10.3390/ijerph18179252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Saudi General Authority for Statistics. Saudi Arabian Census Report for 2010. [Accessed on 3 March 2023]. https://www.stats.gov.sa/en/73.
  • 22.Saudi General Authority for Statistics. The Government Services Guidelines of Jazan Region. 2017. [Accessed on 3 March 2023]. https://www.stats.gov.sa/sites/default/files/jazan_region_ar.pdf.
  • 23.Charan J, Biswas T. How to Calculate Sample Size for Different Study Designs in Medical Research? Indian J Psychol Med 2013;35: 121–126. doi: 10.4103/0253-7176.116232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bakhsh LA, Adas AA, Murad MA, Nourah RM, Hanbazazah SA, Aljahdali AA, et al. Awareness and Knowledge on Hypertension and its Self- Care Practices Among Hypertensive Patients in Saudi Arabia. Annals of International Medical and Dental Research 2017;2: 58–62. [Google Scholar]
  • 25.Alharbi SA, Wedhaya MA, Alrehaili SS, Alluqmani MF. Evaluation of Knowledge in Hypertensive Saudi Population in Makkah, KSA. Egypt J Hosp Med 2017;67: 765–770. doi: 10.12816/0037834 [DOI] [Google Scholar]
  • 26.Al Zahrani S, Eid Alosaimi M, Alamrim AA, Alotaibi M, Almatar EA, Almanea BA. Association between knowledge and drug adherence in patients with hypertension in Saudi Arabia. Arch Pharm Pract 2019;10: 71–76. [Google Scholar]
  • 27.Elsheikh E, Gharash AA, Almohammed B, AlJumaah M, Al Omaish M, Albahrani A. Social knowledge of symptoms, risk factors, causes and complications of hypertension among Al-Ahsa population, Saudi Arabia. Medical Science 2021;25: 1355–1363. [Google Scholar]
  • 28.Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370: 1453–1457. doi: 10.1016/S0140-6736(07)61602-X [DOI] [PubMed] [Google Scholar]
  • 29.Erkoc SB, Isikli B, Metintas S, Kalyoncu C. Hypertension Knowledge-Level Scale (HK-LS): A Study on Development, Validity and Reliability. Int J Environ Res Public Health 2012;9: 1018–1029. doi: 10.3390/ijerph9031018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Alshammari SA, Alajmi AN, Albarrak RA, Alaqil AB, Alsaeed GK, Alzayed MZ, et al. Quality of Life and Awareness of Hypertension Among Hypertensive Patients in Saudi Arabia. Cureus 2021;13:e14879. doi: 10.7759/cureus.14879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sharaf SE, Alharbi YS, Alsharif RS, AlHassani KH, Aldadi SH, Alhawsawi OA, et al. Hypertension self-management and antihypertensive prevalence amid patients in Saudi Arabia via knowledge, attitude, and practice assessment. International Journal of Family & Community Medicine 2021;5: 123–133. doi: 10.15406/ijfcm.2021.05.00233 [DOI] [Google Scholar]
  • 32.Boateng D, Wekesah F, Browne JL, Agyemang C, Agyei-Baffour P, Aikins AD, et al. Knowledge and awareness of and perception towards cardiovascular disease risk in sub-Saharan Africa: A systematic review. PLoS One 2017;12:e0189264. doi: 10.1371/journal.pone.0189264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Asiri AA, Asiri S, Asiri H. Knowledge Related to Hypertension Risk Factors, Diet, and Lifestyle Modification: A Comparative Study Between Hypertensive and Non-Hypertensive Individuals. Cureus 2020;12:e9890. doi: 10.7759/cureus.9890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Agyei-Baffour P, Tetteh G, Quansah DY, Boateng D. Prevalence and knowledge of hypertension among people living in rural communities in Ghana: a mixed method study. Afr Health Sci 2018;18: 931–941. doi: 10.4314/ahs.v18i4.12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Waszak PM, Kasprzycka-Waszak W, Kubanek A. The spread of medical fake news in social media—The pilot quantitative study. Health Policy Technol 2018;7: 115–118. doi: 10.1016/j.hlpt.2018.03.002 [DOI] [Google Scholar]
  • 36.Suarez-Lledo V, Alvarez-Galvez J. Prevalence of Health Misinformation on Social Media: Systematic Review. J Med Internet Res 2021;23:e17187. doi: 10.2196/17187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Van der Tempel J, Noormohamed A, Schwartz R, Norman C, Malas M, Zawertailo L. Vape, quit, tweet? Electronic cigarettes and smoking cessation on Twitter. Int J Public Health 2016;61: 249–256. doi: 10.1007/s00038-016-0791-2 [DOI] [PubMed] [Google Scholar]
  • 38.Merianos AL, Gittens OE, Mahabee-Gittens EM. Depiction of health effects of electronic cigarettes on YouTube. Journal of Substance Use 2016;21: 614–619. doi: 10.3109/14659891.2015.1118565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kumar N, Pandey A, Venkatraman A, Garg N. Are video sharing web sites a useful source of information on hypertension? J Am Soc Hypertens 2014;8: 481–490. doi: 10.1016/j.jash.2014.05.001 [DOI] [PubMed] [Google Scholar]
  • 40.Xu L, Meng Q, He S, Yin X, Tang Z, Bo H, et al. The effects of health education on patients with hypertension in China: A meta-analysis. Health Educ J 2014;73: 137–149. doi: 10.1177/0017896912471033 [DOI] [Google Scholar]
  • 41.Ozoemena EL, Iweama CN, Agbaje OS, Umoke PCI, Ene OC, Ofili PC, et al. Effects of a health education intervention on hypertension-related knowledge, prevention and self-care practices in Nigerian retirees: a quasi-experimental study. Arch Public Health 2019;77: 1–16. doi: 10.1186/s13690-019-0349-x [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Isaac Amankwaa

12 Jan 2024

PONE-D-23-25700Assessing knowledge about hypertension and identifying predictors of inadequate knowledge in the Jazan regionPLOS ONE

Dear Dr. Alhazmi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Required changes for acceptance. I have reviewed the reviewers' comments and outlined below those that need to be addressed before acceptance and those that are recommendations only. 

  • Title & Abstract 
    • Title: Indicate the type of study in the title.
    • Background: state the gap(s) in the current understanding of hypertension in the Jazan region that informed the current study
    • Methods: Include the statistical analysis employed
    • The conclusion section of the abstract should be rephrased according to the main findings of the study (Reviewer 1)
    • The sampling technique and the online questionnaire preclude the presentation of whole area and generalizability of the results. This must be added to the limitation section (Reviewer 1)
  • Introduction
    • Line 84-92 – the author writes ‘These previous studies investigating hypertensive patients' knowledge levels in other Saudi regions cannot be generalized to other Saudi regions, such as the Jazan region, where a higher proportion of people suffer from hypertension and its complications and where the health system is overwhelmed by emergencies and cases of communicable and genetic diseases’ – can you conform whether study with numbered reference 15 (by  Alshammari et al) was conducted in other region of Saudi Arabia?  Or the sample was taken from the whole of Saudi Arabia? If the latter is true, then you will need to refine the statement of your evidence gap.

Recommended changes

  • No need to mention the region of the study to enhance the global significant. You can add the Country name. 

  • All comments by reviewer 2 are recommendations only.

Please submit your revised manuscript by Feb 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Isaac Amankwaa, Ph.D.

Guest Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. No need to ping with follow up.

Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. We note that your Data Availability Statement is currently as follows: "All relevant data are within the manuscript and its Supporting Information files."

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is technically sound, the data support the conclusions and presented in an intelligible fashion. However, minor revision is needed to complete the picture. In the title its very important to indicate the type of the study. No need to mention the region of the study to enhance the global significant. You can add the Country name. The conclusion section of the abstract should be rephrased according to the main findings of the study. The sampling technique and the online questionnaire preclude the presentation of whole area and generalizability of the results. This must be added to the limitation section.

Reviewer #2: It is well written and technically sound.No issues of dual publications and research ethics.Although it attempted to address this important topic there are some critical issues that warrant further attention. These would improve the research's quality and robustness, making it more academic journal-worthy. Points for improvement:

1. Title and Abstract: Text clarity, conciseness and structure can be improved.

2. Literature assessment: A more thorough assessment would strengthen the study's scientific foundation. This would help understand the present state of knowledge and the research gaps the project attempts to address.

3. Methods: More detailed information about the tool for data would be helpful.

4.Discussion: Attention and conciseness can be improved by emphasizing the most important facts and recommendations.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer comments.docx

pone.0299745.s006.docx (12.5KB, docx)
PLoS One. 2024 Mar 18;19(3):e0299745. doi: 10.1371/journal.pone.0299745.r002

Author response to Decision Letter 0


5 Feb 2024

COVER LETTER

Manuscript reference number: PONE-D-23-25700

Title: Assessing knowledge about hypertension and identifying predictors of inadequate knowledge in the Jazan region

Dear Editor,

We would like to thank the Editor for giving us the opportunity to revise the manuscript. The reviewers have some excellent remarks, which we have tried to incorporate in this revised version. Below, we describe point-by-point how we handled the comments from the reviewers on our previous submission. The changes are highlighted using track changes in the manuscript. Page numbers are referring to the document entitled as “Revised Manuscript with Track Changes”.

Editor comment:

Point (Pointed out within the Email that the corresponding author has received):

Line 84-92 – the author writes ‘These previous studies investigating hypertensive patients’ knowledge levels in other Saudi regions cannot be generalized to other Saudi regions, such as the Jazan region, where a higher proportion of people suffer from hypertension and its complications and where the health system is overwhelmed by emergencies and cases of communicable and genetic diseases’ – can you conform whether study with numbered reference 15 (by Alshammari et al) was conducted in other region of Saudi Arabia? Or the sample was taken from the whole of Saudi Arabia? If the latter is true, then you will need to refine the statement of your evidence gap.

Response: We added further information related to study settings (by Alshammari et al) to be “conducted in various regions of Saudi Arabia”. Page 5, line 88. We also refined the statement of our evidence gap to be “As a result of the limited data, there is a need to understand the knowledge in general and specific areas concerning hypertension in this particular region of Saudi Arabia.”. Page 5, lines 97-98.

Reviewer #1

Minor comments:

1.1 The manuscript is technically sound, the data support the conclusions and presented in an intelligible fashion.

Response: Thank you for your appreciation.

1.2 In the title its very important to indicate the type of the study. No need to mention the region of the study to enhance the global significant. You can add the Country name.

Response: Thank you for your remarkable comment. We have incorporated the reviewer’s suggestion into the title to be “Assessing knowledge about hypertension and identifying predictors of inadequate knowledge in Saudi Arabia: A cross-sectional study”. Page 1, line 2.

1.3 The conclusion section of the abstract should be rephrased according to the main findings of the study.

Response: Thank you for your valuable comment. We have omitted “Therefore, to improve patients' knowledge and enhance public health practices in Jazan, involving public health educators in primary health care services could improve patients' knowledge about hypertension and its complications and reduce the burden on family physicians in the Jazan region shown in the literature. Further studies are required to determine the knowledge level of hypertensive patients with severe complications such as cerebral stroke.” and rephrased the conclusion section in the abstract in line with the main findings to be “Diet, medical treatment, disease definition, drug compliance, and complications were subsequently the least knowledgeable subdimensions among the study population. Therefore, these subdimensions should be prioritized when planning hypertension educational interventions and during follow-up sessions, especially for patients of younger age groups and those with lower educational levels.”. Page 3, lines 45-49.

1.4 The sampling technique and the online questionnaire preclude the presentation of whole area and generalizability of the results. This must be added to the limitation section.

Response: We have omitted the statement “Second, using a nonprobability sampling strategy affected the study’s external validity, which could limit its generalizability” and incorporated the reviewer’s suggestion to be “Second, the sampling technique and the online questionnaire preclude the presentation of the whole area and the generalizability of the results.”. Page 19, lines 316-318.

Reviewer #2

Minor comments (recommendations):

2.1 It is well written and technically sound. No issues of dual publications and research ethics. Although it attempted to address this important topic there are some critical issues that warrant further attention. These would improve the research's quality and robustness, making it more academic journal-worthy.

Response: Thank you for your appreciation.

2.2 Title and Abstract: Text clarity, conciseness and structure can be improved.

Response: According to reviewer recommendations, we have improved the text clarity, conciseness, and structure in the title and abstract. Page 1, line 2, page 2, lines 25-27, line 30, lines 34-36, and page 3, lines 45-49.

2.3 Literature assessment: A more thorough assessment would strengthen the study's scientific foundation. This would help understand the present state of knowledge and the research gaps the project attempts to address.

Response: Thank you for your suggestion. We have added further information related to the literature assessment to the introduction section to strengthen the scientific foundation. Page 5, lines 89-91, and lines 97-98.

2.4 Methods: More detailed information about the tool for data would be helpful.

Response: We have added detailed information in the material and methods section; the data collection instrument to be “which was developed by Erkoc et al. in English to assess Turkish adults’ knowledge about hypertension and its management using 22 items that are distributed across six specific areas called subdimensions, namely: disease definition, medical treatment, drug compliance, lifestyle, diet, and complications”, page 8, lines 153-156, and we also added further explanation as the following “an addition of one item to the disease definition subdimension, and it was added to assess participants’ knowledge regarding the increased isolated systolic pressure as a form of hypertension. Also, three items were added to the lifestyle subdimension to evaluate patients’ understanding of the role of salt intake, obesity/overweight, and physical activity as essential factors for managing hypertension.”. Page 8, lines 158-162.

2.5 Discussion: Attention and conciseness can be improved by emphasizing the most important facts and recommendations.

Response: Thank you for your recommendation. The most important facts and recommendations were emphasized in the discussion section. For example, we discussed our findings related to lower level of knowledge that were observed at the overall scale and each subdimension. In addition, we have discussed the uncontrolled hypertension and identified regional structural indicators necessary for dealing with hypertension complications, the co-existence of other prevalent health problems, hypertension misleading information, lack of health professionals, and low adherence to the hypertension guidelines. We also draw the attention of readers and policy-makers to involve health educators in such situations to improve hypertension management.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0299745.s007.docx (26.5KB, docx)

Decision Letter 1

Isaac Amankwaa

16 Feb 2024

Assessing knowledge about hypertension and identifying predictors of inadequate knowledge in Saudi Arabia: A cross-sectional study

PONE-D-23-25700R1

Dear Ajiad Alhazmi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Isaac Amankwaa, Ph.D.

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Isaac Amankwaa

7 Mar 2024

PONE-D-23-25700R1

PLOS ONE

Dear Dr. Alhazmi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Isaac Amankwaa

Guest Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Data.

    Data of eligible participants.

    (XLSX)

    pone.0299745.s001.xlsx (52.8KB, xlsx)
    S1 Table. STROBE checklist.

    STROBE Statement—checklist of items that should be included in reports of observational studies.

    (DOCX)

    pone.0299745.s002.docx (24.5KB, docx)
    S2 Table. Modification details.

    Modifications applied to the HK-LS.

    (DOCX)

    pone.0299745.s003.docx (14.8KB, docx)
    S3 Table. Tests of normality.

    Tests of normality of dependent variables.

    (DOCX)

    pone.0299745.s004.docx (13.4KB, docx)
    S4 Table. Mean ranks.

    Mean ranks of nonparametric tests.

    (DOCX)

    pone.0299745.s005.docx (20.7KB, docx)
    Attachment

    Submitted filename: Reviewer comments.docx

    pone.0299745.s006.docx (12.5KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0299745.s007.docx (26.5KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES